Related references
Note: Only part of the references are listed.A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management
Xilin Sun et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
SPECT imaging evaluation of 111indium-chelated cetuximab for diagnosing EGFR-positive tumor in an HCT-15-induced colorectal xenograft
Bin-Bin Shih et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2017)
PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer
Judith van Loon et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Development and Evaluation of 18F-IRS for Molecular Imaging Mutant EGF Receptors in NSCLC
Yan Song et al.
SCIENTIFIC REPORTS (2017)
Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors
Marine Goux et al.
BIOCONJUGATE CHEMISTRY (2017)
Predictive efficacy of 11C-PD153035 PET imaging for EGFR-tyrosine kinase inhibitor sensitivity in non-small cell lung cancer patients
Dong Dai et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator
Ken G. Andersson et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules
Javad Garousi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model
In Ho Song et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients
Mattias Sandstrom et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Enhanced tumor retention of radioiodinated anti-epidermal growth factor receptor antibody using novel bifunctional iodination linker for radioimmunotherapy
Eun Jung Kim et al.
ONCOLOGY REPORTS (2016)
Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT
Jens Sorensen et al.
THERANOSTICS (2016)
Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake
Qing Cheng et al.
EJNMMI RESEARCH (2016)
PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab
Nikolaos E. Makris et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs
Yanna Tang et al.
ONCOTARGET (2015)
Fluorogen Activating Protein-Affibody Probes: Modular, No-Wash Measurement of Epidermal Growth Factor Receptors
Yi Wang et al.
BIOCONJUGATE CHEMISTRY (2015)
Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall- cell lung cancer
K. Azuma et al.
ANNALS OF ONCOLOGY (2014)
First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule
Jens Sorensen et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
An EGFR Targeted PET Imaging Probe for the Detection of Colonic Adenocarcinomas in the Setting of Colitis
N. Selcan Turker et al.
THERANOSTICS (2014)
Affibody modified and radiolabeled gold-Iron oxide hetero-nanostructures for tumor PET, optical and MR imaging
Meng Yang et al.
BIOMATERIALS (2013)
Imaging of Epidermal Growth Factor Receptor Expression in Head and Neck Cancer with SPECT/CT and 111In-Labeled Cetuximab-F(ab′)2
Laura K. van Dijk et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Translational 18F-FDG PET/CT Imaging to Monitor Lesion Activity in Intestinal Inflammation
Dominik Bettenworth et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Preclinical Comparison of Near-Infrared-Labeled Cetuximab and Panitumumab for Optical Imaging of Head and Neck Squamous Cell Carcinoma
Kristine E. Day et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
Inert coupling of IRDye800CW and zirconium-89 to monoclonal antibodies for single- or dual-mode fluorescence and PET imaging
Ruth Cohen et al.
NATURE PROTOCOLS (2013)
111In-cetuximab-F(ab′)2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts
Laura K. van Dijk et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
Esra A. Akbay et al.
CANCER DISCOVERY (2013)
Evaluation of Four Affibody-Based Near-Infrared Fluorescent Probes for Optical Imaging of Epidermal Growth Factor Receptor Positive Tumors
Shibo Qi et al.
BIOCONJUGATE CHEMISTRY (2012)
Intratumor Heterogeneity: Evolution through Space and Time
Charles Swanton
CANCER RESEARCH (2012)
Discrepancies between primary tumor and metastasis: A literature review on clinically established biomarkers
Stephane Vignot et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model
Weihua Li et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Epidermal growth factor receptor inhibits colitis-associated cancer in mice
Philip E. Dube et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Can EGFR-TKIs be used in first line treatment for advanced non-small cell lung cancer based on selection according to clinical factors ? - A literature-based meta-analysis
Chongrui Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
PET of EGFR Expression with an 18F-Labeled Affibody Molecule
Zheng Miao et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Intratumor Heterogeneity and Branched Evolution
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET
Maria J. W. D. Vosjan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
Bianca A. W. Hoeben et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Molecular Imaging with 11C-PD153035 PET/CT Predicts Survival in Non-Small Cell Lung Cancer Treated with EGFR-TKI: A Pilot Study
Xue Meng et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Non-small-cell lung cancer
Peter Goldstraw et al.
LANCET (2011)
Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib
Vince D. Cataldo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HER1-Targeted 86Y-Panitumumab Possesses Superior Targeting Characteristics than 86Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts
Tapan K. Nayak et al.
PLOS ONE (2011)
Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis
Annette K. Larsen et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets
Ruth Cohen et al.
EJNMMI RESEARCH (2011)
Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Positive Tumor with a 64Cu Labeled Affibody Protein
Zheng Miao et al.
BIOCONJUGATE CHEMISTRY (2010)
Influence of Labelling Methods on Biodistribution and Imaging Properties of Radiolabelled Peptides for Visualisation of Molecular Therapeutic Targets
V. Tolmachev et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount
Vladimir Tolmachev et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
In Vivo Molecular Imaging of Colorectal Cancer With Confocal Endomicroscopy by Targeting Epidermal Growth Factor Receptor
Martin Goetz et al.
GASTROENTEROLOGY (2010)
EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED THERAPY OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Mark E. Sharafinski et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors
Zheng Miao et al.
JOURNAL OF BIOMEDICAL OPTICS (2010)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET
Hugo J. W. L. Aerts et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models
Gang Niu et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
Robert Pirker et al.
LANCET (2009)
Antagonistic effect of EGF on FAK phosphorylation/dephosphorylation in a cell
Sang-Heon Kim et al.
CELL BIOCHEMISTRY AND FUNCTION (2008)
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule
Mikaela Friedman et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression
Lieven Huang et al.
MOLECULAR IMAGING AND BIOLOGY (2008)
Noninvasive monitoring of tumors
Joan H. Schiller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Remodeling a DNA-binding protein as a specific in vivo inhibitor of bacterial secretin PulD
Barbara Mouratou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule
Erika Nordberg et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody
Weibo Cai et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
A phase 1 escalating single-dose and weekly fixed-dose study of cetuximab: Pharmacokinetic and pharmacodynamic rationale for dosing
Paula M. Fracasso et al.
CLINICAL CANCER RESEARCH (2007)
Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor
M. Friedman et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2007)
Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy
Vladimir Tolmachev et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Effect of target dynamics on pharmacokinetics of a novel therapeutic antibody against the epidermal growth factor receptor: Implications for the mechanisms of action
Jeroen J. Lannnerts van Bueren et al.
CANCER RESEARCH (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
N Thatcher et al.
LANCET (2005)
Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases -: Reply
T Gårdmark et al.
BJU INTERNATIONAL (2005)
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
HW Lo et al.
CANCER CELL (2005)
Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas - An immunohistomchemical and fluorescence in situ hybridization study
S Suzuki et al.
CANCER (2005)
Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis - Comparison with the main clinical and pathological prognostic factors
R Molina et al.
TUMOR BIOLOGY (2003)
Preorganized secondary structure as an important determinant of fast protein folding
JK Myers et al.
NATURE STRUCTURAL BIOLOGY (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
